G1 Therapeutics EBITDA Margin 2016-2024 | GTHX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for G1 Therapeutics (GTHX) over the last 10 years. The current EBITDA margin for G1 Therapeutics as of June 30, 2024 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $0.06B | $-0.04B | -62.07% |
| 2024-03-31 | $0.08B | $-0.02B | -25.30% |
| 2023-12-31 | $0.08B | $-0.04B | -45.12% |
| 2023-09-30 | $0.08B | $-0.06B | -76.62% |
| 2023-06-30 | $0.09B | $-0.07B | -73.03% |
| 2023-03-31 | $0.06B | $-0.11B | -193.10% |
| 2022-12-31 | $0.05B | $-0.13B | -255.77% |
| 2022-09-30 | $0.05B | $-0.14B | -291.67% |
| 2022-06-30 | $0.03B | $-0.16B | -551.72% |
| 2022-03-31 | $0.03B | $-0.16B | -648.00% |
| 2021-12-31 | $0.03B | $-0.14B | -440.63% |
| 2021-09-30 | $0.04B | $-0.13B | -297.67% |
| 2021-06-30 | $0.07B | $-0.10B | -147.69% |
| 2021-03-31 | $0.06B | $-0.09B | -148.33% |
